Antibiotic Resistance of Uropathogens Isolated from Patients Hospitalized in District Hospital in Central Poland in 2020.
Barbara KotAgata GrużewskaPiotr SzwedaJolanta WichaUrszula ParulskaPublished in: Antibiotics (Basel, Switzerland) (2021)
The aim of this study was to determine antibiotic resistance patterns and the prevalence of uropathogenes causing urinary tract infections (UTIs) in patients hospitalized in January-June 2020 in central Poland. Antimicrobial susceptibility testing was performed using the disk-diffusion method. Escherichia coli (52.2%), Klebsiella pneumoniae (13.7%), Enterococcus faecalis (9.3%), E. faecium (6.2%), and Proteus mirabilis (4,3%) were most commonly isolated from urine samples. E. coli was significantly more frequent in women (58.6%) (p = 0.0089) and in the age group 0-18, while K. pneumoniae was more frequent in men (24.4%) (p = 0.0119) and in individuals aged 40-60 and >60. Gram-negative species showed resistance to ampicillin. K. pneumoniae were resistant to amoxicillin plus clavulanic acid (75.0%), piperacillin plus tazobactam (76.2%), cefotaxime (76.2%), cefuroxime (81.0%), ciprofloxacin (81.0%), and trimethoprim plus sulphamethoxazole (81.0%). Carbapenems were effective against all E. coli and P. mirabilis. Some K. pneumoniae (13.6%) produced metallo-β-lactamases (MBLs). E. coli (22.6%), K. pneumoniae (81.8%), and all E. faecium were multidrug-resistant (MDR). Some E. coli (26.2%), K. pneumoniae (63.6%), and P. mirabilis (14.3%) isolates produced extended-spectrum beta-lactamases (ESBL). Vancomycin-resistant E. faecium was also found. This study showed that the possibilities of UTIs therapy using available antibiotics become limited due to the increasing number of antibiotic-resistant uropathogens.
Keyphrases
- escherichia coli
- multidrug resistant
- gram negative
- klebsiella pneumoniae
- end stage renal disease
- urinary tract infection
- drug resistant
- ejection fraction
- acinetobacter baumannii
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- respiratory tract
- stem cells
- type diabetes
- cystic fibrosis
- patient reported outcomes
- staphylococcus aureus
- biofilm formation
- south africa
- methicillin resistant staphylococcus aureus
- bone marrow
- middle aged
- acute care
- electronic health record